membranebound
peptidas
play
import
role
regul
local
concentr
variou
signal
peptid
growth
factor
hormon
chemokin
cytokin
accomplish
mean
enzym
activ
recent
membranebound
peptidas
also
shown
act
receptor
receiv
signal
yet
undefin
ligand
transduc
cell
interior
use
either
mechan
peptidas
interact
fundament
cellular
function
growth
differenti
activ
death
studi
address
effect
tcell
deriv
cytokin
interferongamma
ifng
activ
aminopeptidas
n
apn
ectoenzym
process
sever
signal
peptid
cell
myelomonocyt
cell
line
use
model
system
apn
assay
level
mrna
membran
marker
enzym
activ
regul
ifng
found
three
level
direct
regul
timedepend
initi
downregul
seen
hr
onset
treatment
ifng
replac
upregul
andor
hr
upregul
observ
hr
preced
upregul
apn
mrna
reach
maximum
hr
ifnginduc
regul
apn
due
membran
aminopeptidas
n
sinc
could
complet
abrog
apn
block
antibodi
delay
upregul
observ
andor
hr
requir
de
novo
protein
synthesi
could
abrog
cycloheximid
inhibitor
protein
synthesi
possibl
role
endogen
ifnginduc
tgfh
mediat
upregul
could
exclud
sinc
tgfh
found
supernat
ifng
treat
cell
thu
data
show
regul
cell
see
front
matter
j
gabrilovac
life
scienc
wwwelseviercomlocatelifesci
myelomonocyt
origin
tcell
deriv
cytokin
ifng
similar
mechan
might
play
role
inflamm
aminopeptidas
n
apn
ec
also
call
alanyl
aminopeptidas
zincdepend
metallopeptidas
clan
famili
id
gluzincin
hooper
rawl
barrett
cleav
neutral
amino
acid
nterminu
oligopeptid
shipp
look
riemann
et
al
lendeckel
et
al
human
apn
cdna
clone
two
independ
group
show
sequenc
ident
myeloid
marker
olsen
et
al
look
et
al
human
apn
gene
locat
chromosom
look
et
al
watt
willard
span
approxim
kilobas
kb
contain
exon
lerch
et
al
encod
two
rna
transcript
kb
control
two
differ
promot
myeloid
epitheli
olsen
et
al
shapiro
et
al
olsen
et
al
shapiro
apn
membranebound
kda
glycoprotein
type
ii
membran
topolog
express
noncoval
link
homodim
surfac
hematopoiet
well
nonhematopoiet
cell
riemann
et
al
van
der
velden
hulsmann
riemann
outsid
hematopoiet
system
express
epitheli
cell
intestin
kidney
hepatocyt
osteoclast
endometri
cell
fibroblast
endotheli
cell
bone
marrow
stromal
cell
neuron
synapt
membran
shipp
look
lendeckel
et
al
although
convent
accept
myeloid
marker
normal
malign
cell
myeloid
lineag
recent
detect
well
lymphocyt
follow
malign
transform
inflamm
cell
activ
wex
et
al
lendeckel
et
al
riemann
et
al
lendeckel
et
al
sinc
apn
extracellularli
orient
catalyt
domain
classifi
ectopeptidas
capabl
cleav
variou
extracellular
peptid
spectrum
encompass
opioid
peptid
enkephalin
endorphin
neuropeptid
neurokinin
somatostatin
inflammatori
peptid
tuftsin
nformylmetleuph
fmlp
monocyt
chemoattract
protein
vasoact
peptid
angiotensin
iii
kallidin
peptid
extracellular
matrix
shipp
look
riemann
et
al
lendeckel
et
al
contradictori
data
degrad
apn
report
kanayama
et
al
kehlen
et
al
recent
complex
interact
apn
regul
local
concentr
chemokin
suggest
show
inhibitor
apn
bestatin
decreas
degrad
also
increas
product
mishima
et
al
henc
apn
evid
involv
regul
peptidemedi
cellular
respons
activatinginactiv
extracellular
peptid
endow
signal
function
apn
chang
local
concentr
therebi
modifi
transduct
signal
shipp
look
lendeckel
et
al
riemann
sever
membranebound
ectopeptidas
coexpress
mani
cell
ectopeptidas
may
collabor
peptidemedi
cellular
respons
thu
regul
cell
prolifer
adhes
signal
transduct
activ
differenti
transform
kenni
et
al
shipp
look
van
der
velden
hulsmann
lendeckel
et
al
riemann
mani
function
receptor
human
coronaviru
e
cytomegaloviru
soderberg
et
al
yeager
et
al
may
serv
target
receptor
drug
deliveri
tumor
may
contribut
angiogenesi
pasqualini
et
al
bhagwat
et
al
curni
et
al
involv
process
present
peptid
bound
major
histocompat
class
molecul
ii
antigenpres
cell
mononuclear
phagocyt
dendrit
cell
larsen
et
al
amoscato
et
al
play
role
cell
adhes
cellcel
cellmatrix
interact
tumor
cell
migrat
invas
menrad
et
al
saiki
et
al
fujii
et
al
control
cellcycl
prolifer
myeloid
lymphoid
cell
wex
et
al
lendeckel
et
al
lendeckel
et
al
lfhn
et
al
particip
signal
transduct
cascad
myeloid
lymphoid
cell
lendeckel
et
al
santo
et
al
recent
describ
apn
local
lipid
raft
cell
membran
santo
et
al
spite
numer
data
biochem
function
properti
littl
known
exact
physiolog
role
function
blood
cell
suggest
leukocyt
apn
could
degrad
inactiv
proinflammatori
peptid
thu
termin
inflammatori
respons
inde
apn
reduc
chemotact
respons
human
neutrophil
granulocyt
fmlp
tuftsin
kenni
et
al
shipp
look
sinc
apn
repres
cellular
potenti
activ
inactiv
inflammatori
peptid
modul
express
differ
agent
stimuli
may
affect
inflammatori
respons
regul
apn
express
studi
epitheli
endotheli
cell
et
al
van
hal
et
al
kehlen
et
al
fibroblast
et
al
sorrel
et
al
potent
apn
regul
cytokin
addit
strong
upregul
apn
also
obtain
synthet
glucocorticoid
dexamethason
et
al
sorrel
et
al
among
cell
hematopoiet
origin
regul
apn
studi
human
monocytesmacrophag
effect
riemann
et
al
ifng
van
hal
et
al
transform
growth
factorbeta
tgfh
kehlen
et
al
report
although
myeloid
progenitor
cell
matur
granulocyt
express
regul
express
examin
detail
address
therefor
effect
cellderiv
cytokin
ifng
express
cell
human
myelomonocyt
cell
line
model
system
cell
high
level
enzymat
activ
apn
express
strongli
membran
marker
laouar
bauvoi
xu
et
al
apn
determin
level
mrna
membran
marker
enzym
activ
recombin
human
interferongamma
ifng
fitclabel
clone
fitclabel
isotyp
control
bestatin
actinonin
cycloheximid
purchas
sigma
lalapna
purchas
bachem
bestatin
actinonin
lalapna
dissolv
phosphatebuff
salin
solut
pb
store
stock
solut
use
cycloheximid
dissolv
ethanol
store
use
apnblock
nonblock
antibodi
gener
gift
dr
e
j
favaloro
institut
clinic
patholog
medic
research
new
south
wale
australia
cell
line
atcc
maintain
medium
contain
lglutamin
mm
hepe
mm
penicillin
gl
streptomycin
gl
fetal
calf
serum
fc
cell
seed
per
ml
medium
replac
everi
hour
cell
seed
culturepl
presenc
variou
concentr
ifng
control
sampl
cultur
medium
without
ifng
initi
concentr
cell
vari
depend
length
treatment
cellsml
cellsml
achiev
approxim
cell
densiti
end
treatment
calcul
base
growthcurv
show
day
end
incub
time
cell
collect
wash
pb
count
adjust
desir
concentr
subsequ
cell
analys
membran
express
apn
enzym
activ
rna
isol
cell
per
assay
incub
fitclabel
clone
sigma
cat
isotyp
control
mous
kappa
sigma
cat
ag
per
cell
min
wash
cell
resuspend
pb
bsa
analys
facscan
bectondickinson
cell
densiti
express
express
mean
fluoresc
intens
mfi
obtain
antibodi
correct
mfi
obtain
isotyp
control
determin
apn
enzym
activ
cell
pb
mix
apn
substrat
lalapna
final
volum
al
flatbottom
plate
falcon
incub
min
carri
water
bath
constant
shake
reaction
termin
put
sampl
icebath
subsequ
addit
ice
cold
pb
al
per
well
plate
spun
min
g
supernat
al
per
well
transfer
anoth
flatbottom
plate
optic
densiti
od
cellfre
supernat
measur
use
elisa
reader
select
filter
nm
data
express
amount
hydrolys
paranitroanilin
min
per
cell
accord
paranitroanilin
standard
curv
total
cellular
rna
extract
cell
use
dhigh
pure
rna
isolationt
kit
roch
follow
manufactur
instruct
rna
concentr
determin
absorpt
nm
use
spectrophotomet
total
cellular
rna
ag
heat
minut
subsequ
use
templat
first
strand
cdna
synthesi
reaction
mixtur
contain
ag
random
hexadeoxynucleotid
primer
roch
mm
dntp
mix
roch
unit
rnaseinhibitor
roch
mm
dithiothreitol
sigma
revers
transcript
buffer
roch
unit
moloney
murin
leukemia
viru
mmulv
revers
transcriptas
rt
roch
final
volum
al
reaction
mixtur
incub
hour
heat
minut
cdna
synthesis
describ
dilut
time
dnase
rnase
free
water
gibco
store
rt
includ
two
neg
control
rna
sampl
without
mmulv
rt
mmulv
rt
without
rna
templat
housekeep
gene
abl
use
intern
standard
control
presenc
contamin
dna
watzing
lion
predict
size
pcr
amplifi
abl
cdna
bp
reaction
give
bp
fragment
genom
dna
rt
prove
free
contamin
dna
subject
examin
predict
size
amplifi
cdna
apn
bp
sequenc
specif
primer
reaction
condit
use
pcr
defin
tabl
pcr
perform
use
al
cdna
dilut
describ
perkin
elmer
thermocycl
initi
denatur
min
last
extens
step
min
use
pcr
reaction
perform
total
volum
al
unit
taq
polymeras
roch
mm
dntp
roch
pcr
buffer
roch
primer
six
microlit
pcr
reaction
resolv
electrophoresi
agaros
gel
stain
ethidium
bromid
visualis
ultraviolet
light
densitometr
analysi
perform
use
imag
master
vd
softwar
pharmacia
order
obtain
semiquantit
result
pcr
product
apn
housekeep
abl
gene
measur
log
phase
reaction
ie
satur
reach
preliminari
experi
perform
order
determin
number
cycl
would
result
linear
relationship
number
cycl
amount
pcr
pruduct
data
shown
presenc
tgfh
supernat
cultur
treatment
ifng
examin
elisa
follow
manufactur
instruct
promega
cat
sampl
run
duplic
signific
observ
data
statist
evalu
student
ttest
level
signific
set
p
b
timeand
concentrationdepend
effect
ifng
membran
express
shown
fig
effect
depend
durat
treatment
short
exposur
cell
ifng
hr
decreas
wherea
prolong
treatment
hr
increas
express
cell
appli
rang
concentr
ngml
effect
ifng
similar
extent
direct
ie
downa
well
upregul
fig
b
respect
order
test
whether
ifngregul
protein
function
activ
apn
enzym
activ
cell
measur
timeand
concentrationdepend
examin
short
exposur
cell
ifng
hr
decreas
wherea
prolong
exposur
hr
increas
apn
enzym
activ
fig
b
test
concentr
ngml
produc
similar
effect
fig
b
thu
ifnginduc
chang
membran
express
paralel
similar
chang
apn
activ
specif
effect
ifng
membran
aminopeptidas
activ
analys
use
monoclon
antibodi
activ
site
apn
clone
block
apn
enzym
activ
treatment
enabl
elimin
possibl
interfer
cytoplasm
aminopeptidas
crossreact
substrat
alapna
final
concentr
agml
block
apn
enzym
activ
control
sampl
fig
b
abrog
chang
apn
activ
induc
ifng
treatment
nonblock
antibodi
clone
use
control
treatment
cell
antibodi
influenc
ifnginduc
chang
apn
activ
fig
henc
ifng
specif
regul
enzym
activ
membranebound
apn
semiquantit
rtpcr
perform
verifi
whether
observ
regul
membran
associ
parallel
chang
apn
enzym
activ
due
alter
level
mrna
apn
timedepend
effect
examin
short
exposur
ifng
hr
moder
decreas
fig
b
wherea
longer
exposur
hr
increas
express
mrna
fig
fig
f
respect
upregul
mrna
apn
pronounc
hr
treatment
fig
c
sinc
upregul
apn
treatment
ifng
postpon
mrna
hr
membran
protein
level
andor
hr
propos
might
due
indirect
effect
caus
de
novo
synthesis
factor
induc
ifng
order
examin
hypothesi
inhibitor
protein
synthesi
cycloheximid
appli
hr
upregul
becom
detect
cycloheximid
abrog
increas
dosedepend
manner
fig
assum
de
novo
synthesis
protein
might
tgfh
potent
stimul
anoth
cell
line
monocyt
origin
determin
presenc
supernat
ifngtreat
cell
howev
tgfh
found
either
ifng
concentr
ngml
appli
hr
data
shown
data
suggest
ifng
induc
tgfh
secret
cell
would
account
observ
upregul
studi
shown
tlymphocyt
deriv
cytokin
ifng
modul
express
human
myelomonocyt
cell
line
timedepend
manner
downregul
occur
short
exposur
andor
hr
upregul
longer
exposur
andor
hr
chang
enzymat
activ
apn
membran
preced
similar
chang
mrna
apn
ie
maxim
upregul
mrna
record
hr
exposur
ifng
maxim
upregul
occur
hr
ifnginduc
chang
apn
express
complet
abrog
apn
block
antibodi
henc
chang
attribut
membran
aminopeptidas
n
knowledg
first
report
regul
express
ifng
immatur
cell
myelomonocyt
origin
initi
downregul
associ
decreas
apn
activ
well
decreas
mrna
apn
sinc
cell
line
use
model
studi
myelomonocyt
origin
specul
similar
decreas
apn
express
matur
granulocyt
monocyt
site
inflamm
might
help
ensur
high
sustain
concentr
proinflammatori
peptid
earli
stage
inflammatori
process
inde
decreas
apn
express
record
peripher
blood
monocyt
treatment
ifng
van
hal
et
al
sever
inflammatori
peptid
report
substrat
apn
chemokin
weber
et
al
chemotact
peptid
fmlp
shipp
look
tuftsin
xu
et
al
vasoact
peptid
angiotensin
iii
riemann
et
al
fig
abrog
ifnginduc
upregul
cycloheximid
cell
incub
ifng
ngml
hr
control
cell
incub
medium
twentyfour
hour
end
incub
cycloheximid
indic
concentr
ad
incub
continu
hr
end
treatment
hr
ifng
hr
cycloheximid
cell
wash
adjust
concentr
label
isotyp
control
result
express
mfi
mfi
cell
minu
mfi
respect
isotyp
control
present
percentag
control
cell
incub
medium
result
one
two
experi
similar
result
present
open
bar
cell
treat
cycloheximid
hatch
bar
cell
treat
ifng
cycloheximid
addit
suscept
chemokin
degrad
apn
also
report
kanayama
et
al
hand
data
mishima
et
al
suggest
inhibit
apn
also
associ
increas
product
prolong
treatment
cell
ifng
hr
initi
downregul
replac
upregul
increas
apn
enzym
activ
associ
increas
membran
well
increas
level
mrna
apn
similar
data
report
riemann
et
al
van
der
velden
et
al
found
antiinflammatori
cytokin
upregul
andor
apn
renal
bronchial
epitheli
cell
respect
day
treatment
increas
associ
increas
apn
mrna
found
van
hal
et
al
endotheli
cell
day
treatment
recent
tgfh
also
report
upregul
human
monocyt
cell
kehlen
et
al
increas
could
observ
mrna
level
well
level
membran
protein
apn
enzym
activ
intens
chang
induc
tgfh
mrna
n
n
apn
data
present
studi
line
report
kehlen
et
al
ie
maxim
increas
observ
mrna
follow
membran
express
apn
enzym
activ
regulatori
abil
ifng
may
restrict
cell
line
contrast
lowdifferenti
myelomonocyt
cell
express
high
level
cell
line
partli
differeni
toward
monocyt
express
low
level
data
shown
show
ifng
moder
increas
high
basal
level
cell
howev
ifng
strongli
increas
time
low
basal
level
express
cell
initi
decreas
observ
treat
ifng
data
shown
manuscript
prepar
thu
ifng
increas
cell
line
myelomonocyt
monocyt
origin
respect
extent
kinet
increas
differ
kehlen
et
al
studi
regul
tgfh
partli
differenti
monocyt
cell
line
differenti
monocyt
line
found
upregul
pronounc
immatur
matur
cell
view
well
data
apn
regul
ifng
might
relev
cell
myelomonocyt
origin
increas
express
induc
ifng
cell
found
studi
delay
suggest
requir
de
novo
synthesi
secondari
factor
regul
express
directli
inde
ifnginduc
upregul
could
abrog
cycloheximid
dosedepend
manner
demonstr
requir
de
novo
synthesi
protein
tgfh
power
stimul
apn
monocyt
cell
line
kehlen
et
al
check
possibl
candid
found
supernat
ifngtreat
cell
thu
upregul
effect
ifng
could
attribut
tgfh
conclus
strengthen
observ
cell
could
increas
express
upon
stimul
exogen
ad
tgfh
data
shown
also
report
potent
modul
bronchial
epitheli
cell
van
der
velden
et
al
fibroblast
sorrel
et
al
could
exclud
mediat
ifnginduc
upregul
well
margin
transient
increas
cell
hr
treatment
data
shown
similarli
result
studi
et
al
observ
postpon
upregul
glomerul
epitheli
cell
treat
ifng
day
upregul
apn
also
observ
growth
factor
initi
differenti
exampl
laouar
et
al
report
upregul
apn
enzym
activ
cell
induct
differenti
toward
monocyt
granulocytemacrophag
colonystimul
factor
gmcsf
contrast
decreas
apn
express
observ
cell
driven
toward
differenti
granulocyt
retino
acid
potent
regul
apn
express
seem
synthet
glucocorticoid
dexamethason
increas
apn
human
dermal
fibroblast
et
al
synergi
ifng
increas
apn
activ
bronchial
epitheli
cell
van
der
velden
et
al
upregul
apn
nep
dexamethason
propos
addit
mechan
antiinflammatori
immunosuppress
action
van
der
velden
et
al
modul
membran
express
found
studi
parallel
modul
apn
mrna
suggest
causal
relationship
howev
mechan
alter
mrna
express
induc
ifng
clear
may
encompass
alter
transcript
andor
alter
mrna
stabil
result
accru
far
allow
distinct
possibl
wex
et
al
shown
activ
lymphocyt
upregul
apn
mrna
due
increas
stabil
mrna
specif
ifng
induc
modul
apn
enzym
activ
cell
check
use
antibodi
specif
activ
site
apn
thu
block
enzym
activ
favaloro
inde
apn
activ
could
block
cell
addit
block
nonblock
antibodi
complet
abrog
downand
upregul
apn
induc
ifng
treatment
data
strongli
suggest
enzym
activ
regul
ifng
found
studi
due
membran
apn
peptidas
similar
substrat
select
name
intracellular
leucineaminopeptidas
share
substrat
select
apn
could
also
activ
ifng
harri
et
al
due
intracellular
localis
leucineaminopeptidas
could
block
antibodi
initi
downregul
apn
induc
ifng
might
reflect
mechan
inflammatori
cell
ensur
suffici
local
concentr
inflammatori
peptid
onset
inflamm
turn
upregul
apn
prolong
exposur
ifng
may
reflect
quench
mechan
prevent
excess
respons
thu
cytokin
appear
capabl
downand
upregul
cellular
armament
cell
optimis
local
concentr
signal
peptid
addit
observ
apn
regul
ifng
might
also
involv
chang
cellular
prolif
abil
sinc
apn
seem
play
role
regul
cell
growth
lfhn
et
al
summari
data
studi
obtain
level
mrna
membran
protein
enzym
activ
shown
ifng
modul
express
human
myelomonocyt
cell
line
timedepend
manner
initi
downregul
andor
hr
switch
upregul
longer
exposur
andor
hr
postpon
increas
seem
due
de
novo
synthesis
regulatori
protein
tgfh
knowledg
regulatori
mechan
express
matur
monocyt
myeloid
cell
particip
immun
inflammatori
respons
might
help
target
manipul
patholog
state
chronic
inflamm
autoimmun
allerg
diseas
croatian
ministri
scienc
educ
sport
project
pharmaceut
industri
pliva
zagreb
croatia
